2022
DOI: 10.3389/fimmu.2022.1094346
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 and monkeypox co-infection: A rapid systematic review

Abstract: In this paper we aimed to study the characteristics, laboratory data and outcomes of monkeypox virus (MPV) and COVID-19 co-infection. On 2nd October 2022, we used the search term “(“monkeypox virus” OR “MPV” OR “monkey pox” OR “monkeypox”) AND (“COVID-19” OR “COVID 19” OR “novel coronavirus” OR “SARS−CoV−2”)” in five databases to collect the relevant articles. We found three male patients, who had sex with men prior to the infection, had multiple comorbid conditions, were diagnosed with PCR, and were admitted … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 14 publications
(15 citation statements)
references
References 10 publications
0
13
0
Order By: Relevance
“…The most common mechanism for developing such complications in the mpox population is associated with respiratory infections, including viral, 84–88 and superimposed lower respiratory tract bacterial infections 89 . Viral co‐infections, like influenza virus, the severe acute respiratory distress syndrome coronavirus 2 (SARS‐CoV‐2) and HIV, were recently reported among mpox patients 84–88 . SARS‐CoV‐2 is responsible for the coronavirus disease 2019 (COVID‐19), and many affected patients died from direct lung injury 90–94 .…”
Section: Respiratory Complicationsmentioning
confidence: 99%
See 2 more Smart Citations
“…The most common mechanism for developing such complications in the mpox population is associated with respiratory infections, including viral, 84–88 and superimposed lower respiratory tract bacterial infections 89 . Viral co‐infections, like influenza virus, the severe acute respiratory distress syndrome coronavirus 2 (SARS‐CoV‐2) and HIV, were recently reported among mpox patients 84–88 . SARS‐CoV‐2 is responsible for the coronavirus disease 2019 (COVID‐19), and many affected patients died from direct lung injury 90–94 .…”
Section: Respiratory Complicationsmentioning
confidence: 99%
“…Furthermore, Mitjà et al 23 showed that 35 mpox with HIV patients (9%) had respiratory complications, including shortness of breath (N = 12), lung nodules (N = 11), pleural effusion (N = 6), consolidation (N = 4), ground glass changes (N = 3), and miliary pattern (N = 1). The most common mechanism for developing such complications in the mpox population is associated with respiratory infections, including viral, [84][85][86][87][88] and superimposed lower respiratory tract bacterial infections. 89 Viral co-infections, like influenza virus, the severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) and HIV, were recently reported among mpox patients.…”
Section: Management and Prognosismentioning
confidence: 99%
See 1 more Smart Citation
“…It is still unclear whether the new monkeypox outbreak is a distinct phenomenon or if it is exacerbated by the COVID-19 pandemic [ 25 ]. Because of the current small patient sample size, the exact cause-effect relationship between SARS-CoV-2 and MPXV coinfection cannot yet be established [ 25 , 26 ].…”
Section: Introductionmentioning
confidence: 99%
“…Currently, there is no approved antiviral agent or vaccine for dengue fever; however, treatment-oriented medical methods are being used to develop potential agents against DENV . Furthermore, an increase in the number of SARS-CoV-2 and dengue virus co-infection cases has been reported in dengue-endemic areas. Cases of co-infection are of great concern as the risk of infection with two viruses is significantly higher than that of a single virus, and the threat of coronavirus is still prominent. , Therefore, it is essential that a method is developed that can detect DENV in the early stages and prevent the advancement of the disease.…”
mentioning
confidence: 99%